Microbes and microbial toxins: Paradigms for microbial-mucosal interactions II. The integrated response of the intestine to Clostridium difficile toxins

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 280, Issue 2 43-2, 2001, Pages

  Pothoulakis, Charalabos ^a   Lamont, J Thomas ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Intestinal inflammation; Mast cells; Neuropeptides; Neutrophils; Rho proteins

Indexed keywords

ACTIN; BACTERIAL TOXIN; CLOSTRIDIUM DIFFICILE TOXIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEUROPEPTIDE; PROTEIN CDC42; RAC PROTEIN; REACTIVE OXYGEN METABOLITE; RHO A PROTEIN; RHO FACTOR; UNCLASSIFIED DRUG;

CELL DESTRUCTION; CELL INTERACTION; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME GLYCOSYLATION; HUMAN; INTESTINE CELL; LAMINA PROPRIA; LEUKOCYTE ACTIVATION; MACROPHAGE; MAST CELL; MICROFILAMENT; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; REVIEW; TIGHT JUNCTION;

EID: 0034999642     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.2001.280.2.g178     Document Type: Review

References (25)

1. Aktories K and Just I. Monoglucosylation of low-molecular-mass GTP-binding Rho proteins by clostridial cytotoxin. Trends Cell Biol 5: 441-443, 1995.
2. Branka JE, Valletta G, Jarry A, Bou-Hanna C, Lemarre P, Van PN, and Laboisse CL. Early functional effects of Clostridium difficile toxin A on human colonocytes. Gastroenterology 112: 1887-1894, 1997.
3. Castagliuolo I, Keates AC, Qiu BS, Kelly CP, Nikulasson ST, Leeman SE, and Pothoulakis C. Increased substance P responses in dorsal root ganglia and intestinal macrophages during Clostridium difficile toxin A enteritis in rats. Proc Natl Acad Sci USA 94: 4788-4793, 1997.
4. Castagliuolo I, Keates AC, Wang CC, Pasha A, Valenick L, Kelly CP, Nikulasson ST, LaMont JT, and Pothoulakis C. Clostridium difficile toxin A stimulates macrophage inflammatory protein-2 production in rat intestinal epithelial cells. J Immunol 160: 6039-6045, 1998.
5. Castagliuolo I, LaMont JT, Letourneau R, Kelly CP, O'Keane JC, Jaffer A, Theoharides TC, and Pothoulakis C. Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin. Gastroenterology 107: 657-665, 1994.
6. Castagliuolo I, Riegler M, Nikulasson S, Lu B, Gerard C, Gerard NP, and Pothoulakis C. NK-1 receptor is required in Clostridium difficile-induced enteritis. J Clin Invest 101: 1547-1550, 1998.
7. Castagliuolo I, Wang CC, Valenick L, Pasha A, Nikulasson S, Carraway RE, and Pothoulakis C. Neurotensin is a proinflammatory peptide in colonic inflammation. J Clin Invest 103: 843-849, 1999.
8. Flegel WA, Muller F, Daubener W, Fischer HG, Hadding U, and Northoff H. Cytokine response by human monocytes to Clostridium difficile toxin A and B. Infect Immun 59: 3659-3666, 1991.
9. Hall A. Rho GTPases and the actin cytoskeleton. Science 279: 509-514, 1998.
10. He D, Hagen SJ, Pothoulakis C, Chen M, Medina ND, Warny M, and LaMont JT. Clostridium difficile toxin A causes early damage to mitochondria in cultured cells. Gastroenterology 119: 139-150, 2000.
11. Hofmann F, Busch C, and Aktories K. Chimeric clostridial cytotoxins: identification of the N-terminal region involved in protein substrate recognition. Infect Immun 66: 1076-1081, 1998.
12. Hofmann F, Busch C, Prepens U, Just I, and Aktories K. Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin. J Biol Chem 272: 11074-11078, 1997.
13. Keates AC, Castagliuolo I, Qiu B, Nikulasson S, Sengupta A, and Pothoulakis C. CGRP upregulation in dorsal root ganglia and ileal mucosa during Clostridium difficile toxin A-induced enteritis. Am J Physiol Gastrointest Liver Physiol 274: G196-G202, 1998.
14. Kelly CP, Becker SD, Linevsky JK, Joshi MA, O'Keane JK, Dickey BF, LaMont JT, and Pothoulakis C. Neutrophil recruitment in Clostridium difficile toxin A enteritis. J Clin Invest 93: 1257-1265, 1994.
15. Krivan HC, Clark GF, Smith DF, and Wilkins TD. Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Galα1-3Galβ1-4 GlcNAc. Infect Immun 53: 573-581, 1986.
16. Kurose I, Pothoulakis C, LaMont JT, Anderson DC, Paulson JC, Miyasaka M, Wolf R, and Granger DN. Clostridium difficile toxin A-induced microvascular dysfunction. Role of histamine. J Clin Invest 94: 1919-1926, 1994.
17. Moncrief JS and Wilkins TD. Genetics of Clostridium difficile toxin. In: Clostridium difficile, edited by Aktories K and Wilkins TC. Berlin: Springer, 2000, p. 35-54.
18. Pothoulakis C, Castagliuolo I, LaMont JT, Jaffer A, O'Keane JC, Snider M, and Leeman SE. CP-96,345, a specific substance P receptor antagonist inhibits rat intestinal responses to Clostridium difficile toxin A, but not cholera toxin. Proc Natl Acad Sci USA 91: 947-951, 1994.
19. Pothoulakis C, Gilbert J, Cladaras C, Castagliuolo I, Semenza G, Hitti Y, Moncrief JS, Linevsky J, Kelly CP, Nikulasson S, Desai HP, Wilkins TD, and LaMont JT. Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficile toxin A. J Clin Invest 98: 641-649, 1996.
20. Qiu B, Pothoulakis C, Castagliuolo I, Nikulasson S, and LaMont JT. Participation of reactive oxygen metabolites in Clostridium difficile toxin A-induced enteritis in rats. Am J Physiol Gastrointest Liver Physiol 276: G485-G490, 1999.
21. Riegler M, Sedivy R, Pothoulakis C, Hamilton G, Zacherl J, Bischof G, Consentini E, Feil W, Schiessel R, LaMont JT, and Wenzl E. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. J Clin Invest 95: 2004-2011, 1995.
22. Triadafilopoulos G, Pothoulakis C, Weiss R, Giampaolo C, and LaMont JT. Comparative study of Clostridium difficile toxin A and cholera toxin in rabbit ileum. Role of prostaglandins and leukotrienes. Gastroenterology 97: 1186-1192, 1989.
23. Von Eichel-Streiber CV, Boquet P, and Sauerborn M. Large clostridial cytotoxins - a family of glucosyltransferases modifying small GTP-binding proteins. Trends Microbiol 4: 375-382, 1996.
24. Warny M, Keates AC, Keates S, Castagliuolo I, Zacks JK, Aboudola S, Qamar A, Pothoulakis C, LaMont JT, and Kelly CP. p38 MAP kinase activation by C. difficile toxin A mediates monocyte necrosis, IL-8 production and enteritis. J Clin Invest 105: 1147-1156, 2000.
25. Wershil B, Castagliuolo I, and Pothoulakis C. Mast cell involvement in Clostridium difficile toxin A-induced intestinal fluid secretion and neutrophil recruitment in mice. Gastroenterology 114: 956-964, 1998.